Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 291031, 8 pages
http://dx.doi.org/10.1155/2014/291031
Clinical Study

Diagnosis of Latent Tuberculosis in Patients with Systemic Lupus Erythematosus: T.SPOT.TB versus Tuberculin Skin Test

1Department of Internal Medicine, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain
2Department of Infectious Diseases, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain
3Department of Clinical Analysis, University Hospital Virgen de las Nieves, Avenida de las Fuerzas Armadas No. 2, 18004 Granada, Spain

Received 7 February 2014; Revised 8 April 2014; Accepted 9 April 2014; Published 28 May 2014

Academic Editor: Juan-Manuel Anaya

Copyright © 2014 Maria Del Mar Arenas Miras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Peng Lu, Xiu Chen, Li-mei Zhu, and Hai-tao Yang, “Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: A Systematic Review and Meta-analysis,” Lung, vol. 194, no. 3, pp. 447–458, 2016. View at Publisher · View at Google Scholar
  • Jameel Youssef, Shannon A. Novosad, and Kevin L. Winthrop, “Infection Risk and Safety of Corticosteroid Use,” Rheumatic Disease Clinics of North America, vol. 42, no. 1, pp. 157–176, 2016. View at Publisher · View at Google Scholar
  • Cho, Kim, Jung, Um, Jung, Suh, and Hyoun-Ah Kim, “Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA,” Lupus, vol. 25, no. 12, pp. 1341–1348, 2016. View at Publisher · View at Google Scholar
  • Kelvin K. F. Tsoi, William K. K. Wu, Nelson Lee, Sunny H. Wong, Siew C Ng, Qinyan Gao, Lai-Shan Tam, Francis K. L. Chan, Justin C. Y. Wu, and Joseph J. Y. Sung, “Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: A systematic review and meta-analysis,” Thorax, vol. 71, no. 1, pp. 64–72, 2016. View at Publisher · View at Google Scholar
  • Reem Abd El-Moneim Habeeb, Noran Osama El-Azizi, Noha Nagi M. Salah El-Deen, Dahlia Abd El-Mohsen Hussein, Caroline Samy Morad, and Amr Mohammad Hawwash, “Mycobacterium tuberculosis infection in systemic lupus erythematosus patients,” Egyptian Rheumatologist, vol. 39, no. 4, pp. 227–231, 2017. View at Publisher · View at Google Scholar
  • Laura Tamašauskienė, Edita Hansted, Astra Vitkauskienė, Skaidrius Miliauskas, Albinas Naudžiūnas, and Brigita Šitkauskienė, “Use of interferon-gamma release assay and tuberculin skin test in diagnosing tuberculosis in Lithuanian adults: A comparative analysis,” Medicina (Lithuania), vol. 53, no. 3, pp. 159–165, 2017. View at Publisher · View at Google Scholar
  • Gustavo Guimarães Moreira Balbi, Francinne Machado-Ribeiro, Cláudia D.L. Marques, Flávio Signorelli, and Roger Abramino Levy, “The interplay between tuberculosis and systemic lupus erythematosus,” Current Opinion in Rheumatology, vol. 30, no. 4, pp. 395–402, 2018. View at Publisher · View at Google Scholar
  • Haitao Wang, Songlan Wang, Lengnan Xu, and Yonghui Mao, “The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment,” Journal of Investigative Surgery, pp. 1–6, 2019. View at Publisher · View at Google Scholar